CD4 and neoplasm: The simultaneous prominence of the three types cells, CD8+ T cells, activated CD4+ memory T cells and M1 macrophages, implying that co-mutation of FAT3 and LRP1B can be used to predict the cytotoxic effect of lymphocytes against tumor cells and the beneficial response of immunotherapy in LUAD.